Quantel Medical by Lumibird Medical Risk Report

📜 Innovation & R&D

Quantel Medical by Lumibird Medical is actively engaging in innovative efforts and research and development activities. It is notable for pioneering projects and launching new diagnostic aids and systems, indicating a strong commitment to advancing ophthalmological and medical imaging technologies. These efforts reflect the company’s strategic direction toward increasing its product offerings and enhancing its technological capabilities.

• Quantel Medical was recognized as one of the first winners of the France 2030 "Medical Imaging" call for projects on 🗓 November 15, 2023, highlighting its innovative edge in medical technology.
• The company announced the launch of a new dry eye diagnostic aid on 🗓 May 8, 2024, underlining their continuous focus on expanding diagnostic technologies.
• On 🗓 December 8, 2022, Lumibird Medical-Ellex launched the premium YAG/SLT laser Tango Reflex Neo, enhancing their laser product line for ophthalmological applications.
• Ellex/Quantel Medical debuted a dry eye IPL system at the RANZCO virtual conference on 🗓 February 11, 2022, adding to their portfolio of non-invasive eye treatment solutions.